U.S. Software Stock News

NasdaqCM:CLPT
NasdaqCM:CLPTMedical Equipment

ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses

ClearPoint Neuro (CLPT) just posted its FY 2025 numbers with Q4 revenue of US$10.4 million, a basic EPS loss of US$0.27, and trailing twelve month revenue of US$37.0 million alongside a trailing EPS loss of US$0.90. Over recent periods, the company has seen quarterly revenue move from US$7.8 million in Q4 2024 to US$10.4 million in Q4 2025, while quarterly EPS losses shifted from US$0.20 to US$0.27 over the same stretch. For investors, the update sets solid top line progress against ongoing...
NasdaqCM:OVID
NasdaqCM:OVIDBiotechs

Ovid Therapeutics (OVID) Q4 Profit Challenges Ongoing Loss Narrative

Ovid Therapeutics (OVID) closed FY 2025 with fourth quarter revenue of US$0.72 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$7.25 million and a trailing basic EPS loss of US$0.24. Over the past year, the company has seen quarterly revenue move from US$0.08 million in Q4 2024 to US$6.27 million in Q2 2025 and US$0.72 million in Q4 2025. Basic EPS has ranged from a loss of US$0.20 in Q3 2024 to a loss of US$0.17 in Q3 2025 and a profit of US$0.12 in Q4 2025...
NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp (RAMP) Valuation After Predactiv Identity Integration News

Predactiv integration puts LiveRamp’s identity tools in focus LiveRamp Holdings (RAMP) is back in the spotlight after Predactiv announced a new integration that routes offline PII data through LiveRamp’s identity resolution, feeding privacy compliant identifiers into Predactiv’s data platform. This integration, followed by a dedicated LiveRamp special call, raises practical questions for investors about how identity resolution, data collaboration, and monetization of first party PII fit into...
NYSE:ANDG
NYSE:ANDGProfessional Services

Andersen Group (ANDG) Margin Compression Challenges Bullish Community Narratives Despite Revenue Growth

Andersen Group FY 2025 earnings snapshot Andersen Group (ANDG) has just wrapped up FY 2025 with fourth quarter revenue of US$170.3 million, a basic EPS loss of US$0.18, and trailing twelve month revenue of US$838.7 million, alongside a trailing net margin of 6.9% versus 18.5% a year earlier. Over the last six reported quarters, revenue has moved from US$639.1 million on a trailing basis in FY 2023 to US$838.7 million in FY 2025. Quarterly net income has swung between profit and loss as...
NYSE:NRGV
NYSE:NRGVElectrical

Energy Vault Holdings (NRGV) Q4 Revenue Surge Tests Bullish Growth Narratives Against Ongoing Losses

Energy Vault Holdings (NRGV) has posted its FY 2025 numbers with fourth quarter revenue of US$153.3 million and a net loss of US$20.7 million, translating to basic EPS of a US$0.12 loss. On a trailing twelve month basis, revenue sits at US$203.7 million with a net loss of US$103.6 million and basic EPS of a US$0.65 loss. The company’s revenue has moved from US$33.5 million in Q4 2024 to US$153.3 million in Q4 2025, with quarterly basic EPS shifting from a US$0.43 loss to a US$0.12 loss over...
NasdaqGS:WB
NasdaqGS:WBInteractive Media and Services

Weibo (NasdaqGS:WB) Margin Strength And Low P/E Challenge Cautious Earnings Narratives

Weibo (NasdaqGS:WB) has wrapped up FY 2025 with fourth quarter revenue of US$473.3 million and a small loss, with basic EPS at US$0.02, after earlier quarters in the year posted positive EPS. The company has seen revenue move from US$456.8 million in Q4 2024 to US$473.3 million in Q4 2025. Trailing twelve month EPS sits at US$1.88, which sets up a results season where the focus is firmly on how consistently Weibo can convert its US$1.8 billion of trailing revenue into durable margins. See our...
NasdaqGM:LWAY
NasdaqGM:LWAYFood

Lifeway Foods (LWAY) Margin Compression To 5.5% Tests Bullish Growth Narrative

Lifeway Foods (LWAY) just wrapped up FY 2025 with Q4 revenue of US$55.4 million and basic EPS of US$0.17, capping a year in which trailing twelve month revenue reached US$212.5 million and EPS came in at US$0.91. Over the past few quarters, revenue has moved from US$46.1 million in Q1 2025 to US$57.1 million in Q3 and then US$55.4 million in Q4, while quarterly EPS ranged between US$0.17 and US$0.28. This sets the stage for investors to focus on how margins are holding up through this...
NYSE:LC
NYSE:LCConsumer Finance

Is It Time To Reassess LendingClub (LC) After The Recent Share Price Weakness?

Wondering whether LendingClub's current share price reflects its true worth, or if the market is missing something important about the stock. The share price closed at US$13.32, with recent moves including an 8.7% decline over 7 days, a 14.6% decline over 30 days, a 30.3% decline year to date, a 20.0% gain over 1 year, and a 97.0% gain over 3 years, while sitting 27.5% lower over 5 years. These swings have kept LendingClub on many investors' watchlists, as the stock has moved between periods...
NasdaqGS:ICLR
NasdaqGS:ICLRLife Sciences

Is It Time To Reassess ICON (ICLR) After A 48% Yearly Share Price Slide?

If you are wondering whether ICON is starting to look attractively priced or still too risky, the recent share moves give you some clear signals to work with. The stock last closed at US$97.14, after a 7.8% decline over the past week, a 4.5% gain over the past 30 days, and returns of a 48.5% decline year to date and a 47.3% decline over the past year. These swings have kept ICON on the radar for investors who are rechecking what they are willing to pay for contract research businesses...
NYSE:JBL
NYSE:JBLElectronic

Jabil (JBL) Margin Compression To 2.3% Reinforces Skeptical Narratives Despite Growth Forecasts

Jabil's Latest Quarterly Snapshot Jabil (JBL) has just posted another quarter of solid scale, with Q1 2026 revenue of about US$8.3b and basic EPS of US$1.36 setting the tone for its latest update. The company has seen revenue move from roughly US$7.0b in Q1 2025 to about US$8.3b in Q1 2026, while basic EPS has shifted from US$0.89 to US$1.36 over the same period. This provides a clear view of how the top and bottom lines are tracking across the year. With that backdrop, the key question for...
NYSE:TTAM
NYSE:TTAMBasic Materials

Titan America (TTAM) Margin Improvement To 11.1% Tests Skeptical Project Risk Narratives

Titan America (TTAM) FY 2025 earnings snapshot Titan America (TTAM) has wrapped up FY 2025 with fourth quarter revenue of US$405.7 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$1.7 billion and EPS at US$1.01, alongside earnings growth of 11.7% over the last year. The company has seen quarterly revenue move from US$389.8 million in Q4 FY 2024 to US$405.7 million in Q4 FY 2025, with quarterly EPS shifting from US$0.21 to US$0.24 as trailing net income...
NYSE:AGRO
NYSE:AGROFood

Adecoagro (AGRO) TTM Net Loss Challenges Bullish Earnings Turnaround Narrative

Adecoagro (NYSE:AGRO) closed out FY 2025 with Q4 revenue of US$415.9 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$15.4 million. The company has seen quarterly revenue range from US$304.2 million to US$415.9 million over 2025, while EPS has swung between a loss of US$0.18 and a profit of US$0.18, underscoring how sensitive margins remain to operating conditions. See our full analysis for Adecoagro. With the headline numbers set, the next...
NasdaqGS:KMTS
NasdaqGS:KMTSMedical Equipment

Kestra Medical Technologies (KMTS) Revenue Growth Versus Ongoing EPS Losses Tests Bullish Narratives

Kestra Medical Technologies (KMTS) has just posted its latest quarterly update with Q2 2026 revenue of US$22.6 million and a basic EPS loss of US$0.64, alongside a trailing 12 month EPS loss of US$3.44 on revenue of US$74.3 million that highlights the current earnings profile. The company has seen quarterly revenue move from US$14.7 million in Q2 2025 to US$22.6 million in Q2 2026. Over the same period, quarterly basic EPS losses have shifted from US$1.19 in Q2 2025 to US$0.64 in Q2 2026,...
NYSE:WCC
NYSE:WCCTrade Distributors

Is WESCO (WCC) Quietly Becoming a Data Center Powerhouse, and What Does That Mean for Risk?

In the most recent reported quarter, WESCO International posted revenue of US$6.10 billion, up 10% year over year, with organic sales rising 9% and 2025 guidance raised following strong Q3 results. A key driver was the rapidly expanding data center segment, which now accounts for nearly 20% of WESCO’s total revenue, underscoring a meaningful shift in its business mix. Next, we’ll examine how WESCO’s rapidly growing data center business could influence the company’s broader investment...
NasdaqCM:ABEO
NasdaqCM:ABEOBiotechs

Abeona Therapeutics (ABEO) One Off US$152.4m Gain Tests Bullish Profitability Narrative

Abeona Therapeutics (ABEO) closed FY 2025 with Q4 revenue of US$5.4 million and basic EPS of a US$0.37 loss, alongside a net income loss of US$20.5 million. Its trailing twelve month figures show basic EPS of US$1.34 and net income of US$71.2 million on revenue of US$5.8 million. Over recent quarters the company has reported revenue of US$0 in Q3 2025, US$0.4 million in Q2, and US$5.4 million in Q4, with quarterly basic EPS moving from a US$2.07 profit in Q2 to losses of US$0.10 in Q3 and...
NYSE:ADT
NYSE:ADTConsumer Services

A Look At ADT’s (ADT) Valuation After The Barclays Downgrade And Flat 2026 Outlook

Barclays downgrade puts ADT (ADT) earnings outlook in focus Barclays recently cut its rating on ADT (ADT) after the company released fourth quarter fiscal 2025 results, spotlighting flat 2026 earnings and revenue expectations, along with stronger free cash flow and lower leverage. See our latest analysis for ADT. ADT's recent 18% year to date share price decline to $6.54, alongside a 30 day share price return of 16% in the red, suggests momentum has been fading even though the 3 year total...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Internet Group (CRCL) Is Up 17.8% After Board Addition And $1.48B Shelf Registration - Has The Bull Case Changed?

Circle Internet Group, Inc. recently appointed Microsoft executive Kirk Koenigsbauer to its Board of Directors and filed a US$1.48 billion shelf registration for more than 14 million Class A shares tied to an employee stock plan. Koenigsbauer’s cloud and AI background, combined with Circle’s focus on USDC and tokenized finance, underscores how the company is aligning governance and incentives with large scale enterprise and infrastructure ambitions. With renewed analyst optimism around USDC...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

HealthEquity (HQY) Margin Expansion To 16.4% Tests Bearish Cost Narratives

HealthEquity (HQY) has wrapped up FY 2026 with fourth quarter revenue of US$334.6 million and basic EPS of US$0.58, backed by trailing twelve month revenue of about US$1.3 billion and EPS of US$2.50 alongside very large year over year earnings growth of 122.5%. Over recent periods the company has seen quarterly revenue move from US$300.4 million in Q3 FY 2025 to US$334.6 million in Q4 FY 2026, while basic EPS has shifted from US$0.07 to US$0.58, prompting investors to focus on how expanding...
NYSE:VAC
NYSE:VACHospitality

Did a New Sales Chief and Counsel Exit Just Shift Marriott Vacations Worldwide's (VAC) Investment Narrative?

Marriott Vacations Worldwide recently reshaped its leadership team, appointing industry veteran Tony Walker as Executive Vice President and Chief Sales and Marketing Officer while long-serving General Counsel James Hunter stepped down ahead of his planned retirement. This leadership transition brings in deep timeshare and experience-based sales expertise at a moment when the company is working through weak demand, competition, and operational challenges highlighted by recent analyst...
NYSE:MOH
NYSE:MOHHealthcare

Is Molina Healthcare (MOH) Offering Opportunity After Medicaid Contract Concerns And Strong DCF Upside

Wondering if Molina Healthcare at around US$143.96 is a bargain or a value trap? This article focuses squarely on what the current price actually says about the stock. The share price has moved 1.9% over the last week and 6.4% over the last month, but the year-to-date return of 19.3% and 1-year return of 54.6% decline give a very different context to where the stock sits today. Recent news coverage has centered on Molina Healthcare's position in the managed care space, including commentary...
NYSE:SMR
NYSE:SMRElectrical

Does NuScale Power (SMR) Share Price Still Match Its Long Term Nuclear Story?

Wondering whether NuScale Power's current share price still reflects the story you have in mind, or if the stock is now pricing in a very different future. NuScale shares recently closed at US$12.44, with returns of 3.4% over 7 days but a 13.1% decline over 30 days and a 23.7% decline year to date, alongside a 25.0% decline over the last year and gains of 40.4% over 3 years and 25.9% over 5 years. These mixed returns sit against a backdrop of ongoing attention on nuclear energy...
NYSE:CARR
NYSE:CARRBuilding

Carrier Global Backs Heat Geek To Tap European Heat Pump Growth

Carrier Global Ventures, the venture arm of NYSE:CARR, has invested in UK-based residential heat pump platform Heat Geek. The partnership is aimed at accelerating residential heat pump adoption across Europe. The move expands Carrier's presence in electrified heating and digital solutions for homeowners. For you as an investor, this connects directly to Carrier's core role in heating, ventilation and air conditioning, as well as its focus on climate technologies. Heat pumps are an important...
NYSE:GPC
NYSE:GPCRetail Distributors

Is Genuine Parts (GPC) Offering Value After The Recent 30% Share Price Slide

Wondering if Genuine Parts at around US$102.82 is offering real value right now, or if the recent share price moves are a warning sign you should pay attention to. Over the last week the stock has seen a 5.6% decline, with a 30.1% decline over 30 days and a 17.1% decline year to date, set against a 14.3% decline over 1 year and a modest 2.9% gain across 5 years. These moves sit against a backdrop where investors are reassessing auto and industrial parts distributors in general, focusing more...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Assessing Summit Therapeutics (SMMT) Valuation After Jefferies Downgrade And Mixed Quarter

Summit Therapeutics (SMMT) is back in focus after a Jefferies downgrade to Hold, tied to risks around four major 2026 clinical catalysts and a mixed fourth quarter 2025 earnings update. See our latest analysis for Summit Therapeutics. The Jefferies downgrade and mixed fourth quarter 2025 earnings update come after a year where the share price return is weak year to date at a 9.53% decline, despite a very large three year total shareholder return that indicates earlier buyers have already seen...